arrow
L

Lucas V.A. Boersma

St Antonius Hospital
H指数:61
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pulsed Field Ablation as First-Line Therapy for the Treatment of Atrial Fibrillation: a FARADISE Sub-Analysis

脉冲场消融作为心房颤动治疗的一线疗法:一项FARADISE亚组分析

2026-10-140
OAAI
Comparison of Two Pulsed Field Ablation Systems for Atrial Fibrillation: One-Year Outcomes From a Multicenter Registry

比较两种用于心房颤动的心房消融脉冲场系统:一项多中心登记研究的1年结果

2026-05-010
OAAI
Refining Risk Stratification for Primary Prevention ICD Therapy: Insights from Cardiac MRI in the DO-IT Registry

优化一级预防ICD治疗的危险分层:来自DO-IT登记研究中心脏MRI的见解

2026-04-240
OAAI
Performance and Safety of the Extravascular Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy

肥厚型心肌病患者中经皮植入式心律转复除颤器的性能与安全性

2026-03-110
PRE
Left atrial appendage occlusion vs standard of care in high stroke risk atrial fibrillation patients ineligible for anticoagulation: COMPARE-LAAO

左心耳封堵术与标准治疗在因抗凝治疗不适用的高卒中风险心房颤动患者中的比较:COMPARE-LAAO研究

2025-12-010
OAAI
Predicting clinically relevant bleeding in new-onset atrial fibrillation patients initiating oral anticoagulant therapy: External validation of the AF-BLEED score

预测新发心房颤动患者开始口服抗凝治疗时临床相关出血的预测:AF-BLEED评分的外部验证

2025-11-090
PRE
Atrial Fibrillation Recurrence After Left Atrial Appendage Occlusion in Patients Undergoing Ablation

左心耳封堵术后房颤复发:经导管消融患者的临床研究

2025-11-070
OAAI
Real-world experience with the pentaspline pulsed field ablation system: one-year outcomes of the FARADISE registry

真实世界中使用五尖波脉冲场消融系统的经验:FARADISE注册研究的一年结果

2025-09-010
OAAI
Pain after subcutaneous implantable cardioverter-defibrillator implantation: A secondary analysis of the PRAETORIAN-DFT trial

皮下植入式心律转复除颤器植入后的疼痛:PRAETORIAN-DFT试验的二次分析

2025-03-310
OAAI